{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T15:45:19Z","timestamp":1772811919648,"version":"3.50.1"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270827, 81500690, 82170805, 81970679, 82201238"],"award-info":[{"award-number":["82270827, 81500690, 82170805, 81970679, 82201238"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>This study aimed to explore the clinical characteristics of thyroid-associated ophthalmopathy (TAO) with hyperlipidemia and to identify the key lipid indicator.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients with TAO were recruited to this study and divided into two groups based on the presence of hyperlipidemia. TAO patients with hyperlipidemia were further classified based on the type of hyperlipidemia. Basic and clinical information of the patients were collected, and comparisons between groups were carried out. Correlation analyses, regression analyses, and stratified analysis were performed to assess the correlations and relationship of the serum lipids with the ophthalmic indicators.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 273 patients with TAO were recruited, including 158 patients with hyperlipidemia and 115 patients without hyperlipidemia. Patients with hyperlipidemia, especially those with mixed hyperlipidemia, exhibited high intraocular pressure (IOP). Spearman\u2019s correlation analysis and partial correlation analysis showed that apolipoprotein E (ApoE) was positively related to IOP levels after controlling for confounding factors, including age, gender, BMI, smoking history, triiodothyronine (T3), and thyrotropin (thyroid-stimulating hormone, TSH). Moreover, multiple linear regression obtained a regression equation including ApoE, gender, age, and BMI and showed that elevated ApoE levels were associated with elevated IOP [<jats:italic>\u03b2<\/jats:italic> = 0.072, 95% confidence interval (CI) = 0.037\u20130.155, <jats:italic>p<\/jats:italic> = 0.030]. Stratified analysis highlighted the impact of ApoE on IOP in younger patients (\u226448 years), female patients, patients with normal BMI (&amp;lt;24 kg\/m<jats:sup>2<\/jats:sup>), and patients with a shorter course of ophthalmopathy (\u22646 months).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Overall, higher IOP levels were observed in patients with hyperlipidemia, especially those with mixed hyperlipidemia. Notably, a higher ApoE was identified as an independent risk factor for higher IOP. This finding confirmed the close relationship between TAO and lipid metabolism and provides a new insight into the pathogenesis research and the long-term management of TAO.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2024.1484343","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T04:18:42Z","timestamp":1732767522000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Hyperlipidemia and apolipoprotein E are associated with intraocular pressure of thyroid-associated ophthalmopathy in a Chinese population: a cross-sectional study"],"prefix":"10.3389","volume":"15","author":[{"given":"Yu","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huayang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingchen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingqian","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiarui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinbo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hairong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingyin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0905750","article-title":"Graves\u2019 ophthalmopathy","volume":"362","author":"Bahn","year":"2010","journal-title":"N Engl J Med"},{"key":"B2","volume-title":"Thyroid Eye Disease","author":"Shah","year":"2024"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-307399","article-title":"Pathogenesis of thyroid eye disease: review and update on molecular mechanisms","volume":"100","author":"Khong","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s12886-024-03569-5","article-title":"Optical coherence tomography angiography in thyroid associated ophthalmopathy: a systematic review","volume":"24","author":"Rajabi","year":"2024","journal-title":"BMC Ophthalmol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/life12122084","article-title":"Thyroid eye disease","volume":"12","author":"Rashad","year":"2022","journal-title":"Life (Basel)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2528046","DOI":"10.1155\/2022\/2528046","article-title":"Cytokines in thyroid-associated ophthalmopathy","volume":"2022","author":"Zhang","year":"2022","journal-title":"J Immunol Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy422","article-title":"Cause of kidney disease and cardiovascular events in a national cohort of US patients with end-stage renal disease on dialysis: a retrospective analysis","volume":"40","author":"O\u2019Shaughnessy","year":"2019","journal-title":"Eur Heart J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1210\/clinem\/dgac252","article-title":"Future projections in thyroid eye disease","volume":"107","author":"Barbesino","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab070","article-title":"Statins decrease the risk of orbitopathy in newly diagnosed patients with graves disease","volume":"106","author":"Nilsson","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2017.0430","article-title":"High serum cholesterol is a novel risk factor for graves\u2019 Orbitopathy: results of a cross-sectional study","volume":"28","author":"Sabini","year":"2018","journal-title":"Thyroid"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-018-0915-z","article-title":"Relationship between serum cholesterol and Graves\u2019 orbitopathy (GO): a confirmatory study","volume":"41","author":"Lanzolla","year":"2018","journal-title":"J Endocrinol Invest"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/cen.2019.90.issue-1","article-title":"Factors associated with the efficacy of intravenous methylprednisolone in moderate-to-severe and active thyroid-associated ophthalmopathy: A single-centre retrospective study","volume":"90","author":"Hu","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1530\/ETJ-23-0109","article-title":"Predicting glucocorticoid effectiveness in thyroid eye disease: combined value from serological lipid metabolism and an orbital MRI parameter","volume":"13","author":"Zhang","year":"2024","journal-title":"Eur Thyroid J"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-015-0762-z","article-title":"Statin reduces orbitopathy risk in patients with Graves\u2019 disease by modulating apoptosis and autophagy activities","volume":"53","author":"Bifulco","year":"2016","journal-title":"Endocrine"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00238-2","article-title":"Statins for Graves\u2019 orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial","volume":"9","author":"Lanzolla","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"8888913","DOI":"10.1155\/2021\/8888913","article-title":"Simvastatin inhibits CYR61 expression in orbital fibroblasts in graves\u2019 Ophthalmopathy through the regulation of foxO3a signaling","volume":"2021","author":"Wei","year":"2021","journal-title":"Mediators Inflammation"},{"key":"B17","doi-asserted-by":"publisher","first-page":"dgaa124","DOI":"10.1210\/clinem\/dgaa124","article-title":"Evidence for associations between th1\/th17 \u201cHybrid\u201d Phenotype and altered lipometabolism in very severe graves orbitopathy","volume":"105","author":"Fang","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.14291","article-title":"Changes in the gut microbiota of patients with Graves\u2019 orbitopathy according to severity grade","volume":"51","author":"Zhang","year":"2023","journal-title":"Clin Exp Ophthalmol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001062","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: A report of the american college of cardiology\/american heart association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1069259","article-title":"Long-term sclerosing therapy of bleeding esophageal varices. A prospective course study","volume":"109","author":"Sauerbruch","year":"1984","journal-title":"Dtsch Med Wochenschr"},{"key":"B21","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/joim.v292.5","article-title":"Current concepts regarding Graves\u2019 orbitopathy","volume":"292","author":"Bartalena","year":"2022","journal-title":"J Intern Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.18240\/ijo.2022.07.17","article-title":"Visual acuity of urban and rural adults in a coastal province of southern China: the Fujian Eye Study","volume":"15","author":"Li","year":"2022","journal-title":"Int J Ophthalmol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0253-3758.2016.10.005","article-title":"2016 Chinese guideline for the management of dyslipidemia in adults","volume":"44","year":"2016","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"B24","doi-asserted-by":"publisher","first-page":"8787","DOI":"10.3390\/ijerph19148787","article-title":"Prevalence, management, and associated factors of obesity, hypertension, and diabetes in tibetan population compared with China overall","volume":"19","author":"Peng","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000002310","article-title":"Associations between thyroid eye disease and glaucoma among those enrolled in the national institutes of health all of us research program","volume":"39","author":"Delavar","year":"2023","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-022-05760-0","article-title":"Ocular hypertension in patients with active thyroid-associated orbitopathy: a predictor of disease severity, particularly of extraocular muscle enlargement","volume":"260","author":"Karhanov\u00e1","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-020-04733-5","article-title":"Relationship between the 24-h variability of blood pressure, ocular perfusion pressure, intraocular pressure, and visual field defect in thyroid associated orbitopathy","volume":"258","author":"Tu","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"9879503","DOI":"10.1155\/2021\/9879503","article-title":"The clinical features of graves\u2019 Orbitopathy with elevated intraocular pressure","volume":"2021","author":"Fan","year":"2021","journal-title":"J Ophthalmol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3390\/diagnostics14060649","article-title":"Correlation between structural and functional changes in patients with raised intraocular pressure due to graves\u2019 Orbitopathy","volume":"14","author":"Bagatin","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S205112","article-title":"Prevalence of increased intraocular pressure in patients with Graves\u2019 ophthalmopathy and association with ophthalmic signs and symptoms in the north-west of Iran","volume":"13","author":"Eslami","year":"2019","journal-title":"Clin Ophthalmol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.09.016","article-title":"Epidemiologic characteristics of intraocular pressure in the Korean and Mongolian populations: the Healthy Twin and the GENDISCAN study","volume":"119","author":"Lee","year":"2012","journal-title":"Ophthalmology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ejim.2011.06.002","article-title":"Age- and gender-specific association between intraocular pressure and metabolic variables in a Taiwanese population","volume":"23","author":"Lin","year":"2012","journal-title":"Eur J Intern Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2015.37","article-title":"Apolipoprotein B: novel indicator of elevated intraocular pressure","volume":"29","author":"Son","year":"2015","journal-title":"Eye (Lond)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010360","article-title":"Evaluation of the associations between changes in intraocular pressure and metabolic syndrome parameters: a retrospective cohort study in Japan","volume":"6","author":"Yokomichi","year":"2016","journal-title":"BMJ Open"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2022.04.023","article-title":"The association between serum lipids and intraocular pressure in 2 large United Kingdom cohorts","volume":"129","author":"Madjedi","year":"2022","journal-title":"Ophthalmology"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.21037\/qims-23-44","article-title":"Prognostic value of extraocular muscles for intraocular pressure in thyroid-associated ophthalmopathy patients","volume":"13","author":"Tian","year":"2023","journal-title":"Quant Imaging Med Surg"},{"key":"B37","doi-asserted-by":"publisher","first-page":"107795","DOI":"10.1016\/j.exer.2019.107795","article-title":"Update on the genetics of primary open-angle glaucoma","volume":"188","author":"Youngblood","year":"2019","journal-title":"Exp Eye Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yexmp.2018.11.004","article-title":"Molecular biomarkers of Graves\u2019 ophthalmopathy","volume":"106","author":"Longo","year":"2019","journal-title":"Exp Mol Pathol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2023.1176690","article-title":"Role of white matter hyperintensity in effects of apolipoprotein E on cognitive injury","volume":"17","author":"Raber","year":"2023","journal-title":"Front Hum Neurosci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.ccell.2023.02.004","article-title":"Apolipoprotein E induces pathogenic senescent-like myeloid cells in prostate cancer","volume":"41","author":"Bancaro","year":"2023","journal-title":"Cancer Cell"},{"key":"B41","doi-asserted-by":"publisher","first-page":"112196","DOI":"10.1016\/j.celrep.2023.112196","article-title":"APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge","volume":"42","author":"Lee","year":"2023","journal-title":"Cell Rep"},{"key":"B42","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/s41590-024-01830-z","article-title":"Apolipoprotein E controls Dectin-1-dependent development of monocyte-derived alveolar macrophages upon pulmonary \u03b2-glucan-induced inflammatory adaptation","volume":"25","author":"Theobald","year":"2024","journal-title":"Nat Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.4158\/EP-2019-0133","article-title":"ROLE OF MAGNETIC RESONANCE IMAGING IN THE ASSESSMENT OF ACTIVE THYROID-ASSOCIATED OPHTHALMOPATHY PATIENTS WITH LONG DISEASE DURATION","volume":"25","author":"Zhou","year":"2019","journal-title":"Endocr Pract"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2021.10.017","article-title":"Teprotumumab efficacy, safety, and durability in longer-duration thyroid eye disease and re-treatment: OPTIC-X study","volume":"129","author":"Douglas","year":"2022","journal-title":"Ophthalmology"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1484343\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T04:18:48Z","timestamp":1732767528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1484343\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":44,"alternative-id":["10.3389\/fendo.2024.1484343"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1484343","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]},"article-number":"1484343"}}